Givaudan S&E
This article was originally published in The Rose Sheet
Executive Summary
Fine fragrance revenue grew by double digits for the first nine months due to significant new launches and strong performance of specialty retail and direct-selling channels, Givaudan reports Oct. 9. Consumer Products business experienced high single-digit growth in local currencies with strong win rates achieved in hair care. Fragrance division sales fell 1.7% to $643.9 mil. (CH1=$.76). In local currencies, division sales were up 5.2%. Givaudan's net sales for the period grew 1.1% in Swiss Francs on a reported basis to $1.58 bil. Revenue was down 4.6% on a pro forma basis, assuming the acquisition of Nestle's flavor activities had taken place Jan. 1...
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.